Showing 1111-1120 of 3980 results for "".
Noah Worcester 2024: Dr. Bhatia on Actinic Keratosis
https://practicaldermatology.com/conferences/noah-worcester-2024/noah-worcester-2024-dr-bhatia-actinic-keratosis/24585/Neal Bhatia, MD, FAAD, summarizes his lecture on actinic keratosis and photodynamic therapy at the 2024 Noah Worcester Dermatological Society meeting.Evolving Atopic Dermatitis Therapeutic Capabilities
https://practicaldermatology.com/videos/c-suite-chats/evolving-atopic-dermatitis-therapeutic-capabilities/67100/J. Mark Jackson, MD, FAAD, Senior Vice President, Clinical Development for Evommune, discusses the importance of improved efficacy and safety for underserved patients with atopic dermatitis.Noah Worcester 2024: Dr. Greenberg on the Society
https://practicaldermatology.com/conferences/noah-worcester-2024/noah-worcester-2024-dr-greenberg-society/24588/Michael Greenberg, MD, president of the Noah Worcester Dermatological Society, speaks at the organization’s 2024 meeting about what makes the event special.When Can Atopic Dermatitis Patients Come off Therapy?
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/program-name/57016/Elizabeth (Lisa) Swanson, MD, addresses the common question of how long a pediatric patient may need to be on a medication for atopic dermatitis as opposed to psoriasis.DermWire TV Extra: Dr. Swanson on BPO
https://practicaldermatology.com/videos/dermwire-tv/dermwire-tv-extra-dr-swanson-bpo/29166/Practical Dermatology Editorial Board member Elizabeth (Lisa) Swanson, MD, FAAD, addresses the recent news involving the safety of benzoyl peroxide products.Itch Be Gone
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/itch-be-gone/18524/Could botulinum toxins be the answer for non-histaminergic itch? Erin Gilbert, MD discusses her research in this area and results she's seen to date.The Effect of the Microbiome
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/the-effect-of-the-microbiome/48776/Zoe Diana Draelos, MD, discusses the evolving role of skin microbiome dysbiosis, particularly Staphylococcus aureus, in perpetuating inflammation in atopic dermatitis.How do barrier dysfunction proteins interact with immune dysregulation to sustain AD?
https://practicaldermatology.com/videos/dermatology-hub-neuroimmune-network/how-do-barrier-dysfunction-proteins-interact-with-immune-dysregulation-to-sustain-ad/56736/Raj Chovatiya, MD, PhD, MSCI, FAAD, discusses whether barrier dysfunction drives inflammation and immune dysregulation, or vice versa, or both, in atopic dermatitis.Noah Worcester 2024: Dr. Webster on Isotretinoin
https://practicaldermatology.com/conferences/noah-worcester-2024/noah-worcester-2024-dr-webster-isotretinoin/24581/Guy Webster, MD, PhD, FAAD, summarizes his lecture on new developments in isotretinoin at the 2024 Noah Worcester Dermatological Society meeting.Noah Worcester 2024: AAD President Dr. Desai on the AAD
https://practicaldermatology.com/conferences/noah-worcester-2024/noah-worcester-2024-dr-desai-aad/24589/Seemal Desai, MD, FAAD, president of the American Academy of Dermatology, summarizes his AAD update presentation at the 2024 Noah Worcester Dermatological Society meeting.